A BSTRACT
Sensitivity analysis is commonly used to characterize the effects of parameter perturbations on model output. One use for the approach is the optimization of an experimental design enabling estimation of model parameters with improved accuracy. The primary objective of this study is to conduct a sensitivity analysis of selected target-mediated pharmacokinetic models, ascertain the effect of parameter variations on model predictions, and identify infl uential model parameters. One linear model (Model 1, control) and 2 target-mediated models (Models 2 and 3) were evaluated over a range of dose levels. Simulations were conducted with model parameters being perturbed at the higher and lower ends from literature mean values. Profi les of free plasma drug concentrations and their partial derivatives with respect to each parameter vs time were analyzed. Perturbations resulted in altered outputs, the extent of which refl ected parameter infl uence. The model outputs were highly sensitive to perturbations of linear disposition parameters in all 3 models. The equilibrium dissociation constant ( K D ) was less infl uential in Model 2 but was infl uential in the terminal phase in Model 3, highlighting the role of K D in this region. An equation for Model 3 in support of the result for K D was derived. Changes in the initial receptor concentration [ R tot (0) ] paralleled the observed effects of initial plasma volume ( V c ) perturbations, with increased infl uence at higher values. Model 3 was also sensitive to the rates of receptor degradation and internalization. These results suggest that informed sampling may be essential to accurately estimate infl uential parameters of target-mediated models.
INTRODUCTION
Dose-dependent pharmacokinetic parameters are a hallmark of target-mediated drug disposition (TMDD), where the interaction between a drug and its pharmacological target 
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Submitted: March 14 , 2007 ; Accepted: May 3 , 2007 ; Published: June 8, 2007 Anson K. Abraham , 1 Wojciech Krzyzanski , 1 and Donald E. Mager 1 1 Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, NY 14260 infl uences the time course of plasma concentration-time profi les. 1 Drugs that exhibit this phenomenon generally show a decreasing volume of distribution with increasing dose levels, and nonlinear clearance also may result if binding to the target is involved in a major elimination pathway (eg, receptor-mediated endocytosis). A general pharmacokinetic model of TMDD has been developed, where these nonlinear properties manifest from the formation and disposition of the drug-target complex. 2 This systematic approach has shown utility in characterizing the complex nonlinear pharmacokinetics of several small-molecule and peptidebased drugs. 3 One challenge to applying the general TMDD model is the estimation of the drug -target binding constants of association and dissociation ( k on and k off ) from in vivo pharmacokinetic data. Formation of the drug-target complex is relatively rapid with respect to kinetics, and common blood sampling schemes make it diffi cult or impossible to estimate these parameters for most drugs. Although various techniques may be applied to limit parameter space, a quasiequilibrium solution of the general model has been derived that replaces the binding microconstants with the equilibrium dissociation constant ( K D = k off / k on ). 4 The quasi-equilibrium model (QEM) was applied to leukemia inhibitory factor (LIF) pharmacokinetic data in sheep; these data had been characterized previously using the TMDD model. 5 Predicted concentration-time profi les appeared to be identical in the 2 models, and there was good agreement in parameter estimates, with the exception of the K D term. Although several explanations might exist, it was hypothesized that the model may be insensitive to K D values. One of the purposes of this study was to ascertain the effect of K D perturbations on TMDD model-predicted outcomes.
Sensitivity analysis is widely used in mathematical modeling to determine the infl uence of parameter values on response variables, which might provide a means for dimension reduction, and to design informative experiments for enabling the accurate estimation of sensitive parameters. 6 The various techniques of sensitivity analysis 7 have been applied to pharmacokinetic systems ranging in complexity from 1-compartment to full physiologically based models. [8] [9] [10] [11] The primary objective of this study is to conduct a sensitivity analysis of selected target-mediated pharmacokinetic models, ascertain the effect of parameter variations on model predictions, and identify infl uential model parameters.
METHODS

Structural Models
Three models were selected for analysis: Model 1, a standard 2-compartment linear model; Model 2, a nonlinear model with receptor binding and a constant receptor pool (ie, drug-receptor complex internalization does not occur and there is no receptor turnover); and Model 3, the QEM solution to the general TMDD model ( Figure 1 ). Nominal parameter values and the applicability of each parameter in the above models are listed in Table 1 . As shown in Figure  1 , Models 1 and 2 are nested versions of the full Model 3. Although any input function may be incorporated into the model structures, only rapid intravenous (IV) injection will be considered. For Model 3, free drug in the central compartment ( C ) can bind to free receptor ( R ) and is in rapid equilibrium with the drug-receptor complex ( RC ). The volume of the central compartment is denoted as V c . Free drug is also available for elimination from the central compartment by a fi rst-order process ( k el ) as well as nonspecifi c distribution to tissue sites by fi rst-order distribution processes ( k pt and k tp ). The drug receptor complex may be internalized and is denoted by a fi rst-order rate constant, k int . The turnover process of free receptor is governed by a zero-order production rate, k syn , and a fi rst-order degradation rate, k deg .
The differential equations describing the QEM model are as follows 4 :
where C tot = C + RC and R tot = R + RC . The drug concentration in the central compartment is the solution to a quadratic equilibrium equation:
Assuming no prior drug exposure (ie, no endogenous production), the initial conditions for the above system are defi ned as follows:
The free receptor synthesis rate was calculated from the baseline equation
With no internalization of the receptor complex or turnover of free receptors, Model 3 simplifi es to 1 of several nonlinear pharmacokinetic models originally described by Wagner (Model 2). 12
Derivation of l z for Model 3
By defi nition, the l z for the free drug concentration is the negative slope of the terminal part of C vs t curve in the semilogarithmic scale:
To calculate the derivative dC/dt , we will use the quasiequilibrium assumption:
After multiplying both sides of Equation 7 by ( C tot -C ) and differentiating with respect to time, we obtain Equation 8:
For large amounts of time, R tot and C tot approach their steady states: 
To calculate the limit in Equation 12 , we can divide Equation 1 by C and let t → ∞ :
where
L ' Hospital ' s rule states:
Equations 15a and 13 imply that
and Equations 15b and 2 yield
Solving Equations 16 and 17 for x results in
Equations 15a and 12 imply that
Equations 18 and 19 can be combined to obtain
Hence, the smallest positive solution is 
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Sensitivity Analysis
As part of a preliminary analysis, a one-at-a-time sensitivity measure/analysis approach was adopted. 13 The partial derivative of model output with respect to the perturbed parameter provides a measure of the model sensitivity to each parameter. Nominal parameter values were taken from the previous analysis of LIF pharmacokinetic data. 4 IV bolus doses for the simulation, obtained from the doseranging study of LIF in sheep, are 12.5, 25, 100, 250, 500, and 750 μg/kg. 5 A generic model code was written in WinNonlin (Pro V 4.1, Pharsight, Mountain View, CA), allowing for logfold alterations in parameter values and/or transition between the different models by setting parameters that are not applicable to a model to the null value. In addition to the transition between the different models, the code could be used to account for endogenous production of the molecule, as necessary. For Model 1, the parameters k int , k deg , and R 0 from Model 3 were set to zero, which in effect reduced the QEM model to a simple 2-compartment model. Model 2 accounts for receptor binding; parameters k deg and k int were set to zero. The resultant model is a 2-compartment model with rapid nonlinear binding in the central compartment and a constant receptor pool. 12 A series of simulations were conducted with differing parameter values, which were varied 10-, 100-, and 1000-fold on the lower and higher side of the LIF base value. 5 Each simulation was conducted by altering 1 parameter at a time and fi xing all remaining parameter values. All simulations were performed using WinNonlin. The outputs considered for the subsequent parameter sensitivity analysis were the simulated concentration-time profi les and partial derivative plots of concentration with respect to the altered parameter. The 250 μg/kg dose was selected for parameter perturbations, as this intermediate dose encompassed the linear as well the transient nonlinear receptor saturation phase. Profi les were generated up to a 25-hour time point, with 501 observations per run. The parameter perturbations are in the log-fold range and may not be physiologically relevant. However, the purpose of the analysis was to test the sensitivity of the model by subjecting it to extreme parametric value perturbations and to ascertain which parameters infl uence the model output. In addition, partial derivatives for each parameter at the nominal value were normalized to the parameter and concentration for each time point: ∂ C / ∂ P × P / C , where P is the parameter of interest. Such normalized sensitivity coeffi cients may be used to assess the relative sensitivity of concentrations (or system output) across model parameters. 7
RESULTS AND DISCUSSION
The simulated concentration-time profi les for the different dose levels are provided in Figure 2 . As expected, the resultant pharmacokinetic profi le from Model 1 is biexponential and the terminal phase is parallel for each dose. Table 1 .
Model 2 incorporates receptor binding, and profi les indicate a subtle triphasic profi le for drug concentrations above the K D value, which is attributed to the nonlinear receptor saturation phase. The terminal phase for each dose is parallel at earlier times but is expected to converge at later times. 2 Model 3 is characterized by a rapid initial drop, followed by the intermediate nonlinear receptor saturation phase, which is clearly seen for the 250, 500, and 750 μg/ kg dose levels.
Simulated free receptor profi les for Models 2 and 3 are shown in Figure 3 . Profi les for Model 2 are consistent with basic expectations from the respective concentration-time profi les for each dose level. The free receptor concentration shows a rapid drop, as a result of receptor binding for the high ligand concentration at earlier times. For higher doses, the concentration of the free receptor remains at the plateau for longer times, until free ligand is slowly eliminated from the system relative to the K D value. Free receptor concentration eventually returns to baseline levels after complete elimination of the ligand, with an expected right shift for increasing dose levels. In Model 3, the initial drop is similar to Model 2 ' s; however, the return to baseline is much more gradual for the higher dose levels. This is the result of a complex interplay between elimination, drug-receptor internalization, and receptor turnover.
Whereas total receptor concentration ( R tot ) for Model 2 remains constant, the total receptor profi le for Model 3 ( Figure 4 ) plateaus at a lower limiting value for higher dose levels before gradually returning to baseline. The concentration of R tot does not reach a limiting value of zero, owing to the receptor turnover process. The return of total receptors to baseline is explained by an increase in the free receptor as drug is eliminated from the system. Table 1 . Table 1 .
Sensitivity Analysis
The model outputs were found to be highly sensitive to parameter perturbations of linear drug disposition ( k el , V c , k pt , and k tp ) for each of the 3 models (data not shown).
Given the focus of this study on the sensitivity of model output to perturbations in parameters associated with nonlinear binding ( K D , R 0 , k int , and k deg ) and the fact that Model 1 does not incorporate nonlinear binding, further discussion will be limited to the evaluation of outputs for the nonlinear system parameters of Models 2 and 3.
Model outcomes following variations in K D are shown in Figure 5A . The perturbations at the lower end of the base parameter values are denoted by the letter L and at the higher end by the letter G. The fold variations are denoted by numerals corresponding to the extent of variation. For example, L1000 would be a 1000-fold change in the parameter at the lower end from the base value of the parameter. Simulations were performed to 100 hours for 
which derives from setting k int = 0 in the equation for the terminal slope of Model 3 (see Equation 21 ). The infl ection point for each of the K D -varied curves coincides with the peaks obtained from the partial derivative curve ( Figure 5B ). One may argue that in order to accurately estimate the parameter K D , one must have measurements at later times coinciding with the partial derivative peaks. This might be complicated by the assay limit of quantifi cation, and a sensitive assay would be required to detect the drug at later times.
The Figure 6A shows differences in C 0 values for perturbations in R 0 and is evident at the higher end of parameter perturbations. The resultant output due to changes in parameter R 0 parallels the changes seen with perturbations in the volume of distribution (data not shown). Free drug is rapidly acquired by free receptor, thus effectively reducing the initial free concentration of the drug in the central compartment. For Model 3, the degradation of the free receptor and internalization of the drug-receptor complex offsets this rapid drop in free drug concentrations for higher-end variations of R 0 , as shown for Model 2. The initial drop is less steep, with a clearly discernible a phase. Models 2 and 3 are both sensitive to the parameter for variations at the higher end of parameter perturbation. Model 3 is most sensitive to nonlinear receptor binding in the a phase. With reference to the partial derivatives, it is evident that the maximum information about R 0 is at early time points. From a study design perspective, it is often diffi cult to obtain blood samples so soon after drug administration.
Model 3 includes important parameters related to receptor turnover and receptor-complex internalization processes ( k int and k deg ). Equation 21 implies that the terminal slope variations are infl uenced by changes in k int as well as changes in K D . Simulated profi les following perturbations of k int are shown in Figure 7 . As expected, no change was observed for the model predictions at earlier times when the free concentrations were above the K D . The convex infl ection point of the concentration profi les for all perturbations of k int , except L100 and L1000, occur at roughly The partial derivatives for all variations of k int ( Figure 7B ) , with the exception of L100 and L1000, result in a peak at 5 hours. Sampling at the 5-hour time point again seems to be crucial for the chosen dose level. The partial derivative plots for the L100 and L1000 perturbations of k int necessitate the incorporation of a sampling beyond 5 hours, perhaps because the concentration approaches the K D at these later time points. 
The parallel terminal slopes observed for the higher-end variations of k deg have a limiting value given by Equation 24, and the infl ection point for each variation is independent of K D . The lower-end variations were relatively insensitive in the initial phase of decline, and the infl ection point for these variations occurs when free concentrations approach the K D value. Also, increasing the receptor degradation rate constant resulted in an overall decreased exposure to free drug. For concentrations above the K D , the model is sensitive to variations of k deg at the higher end of the parameter space.
Finally, whereas local sensitivity analysis reveals sampling points where maximum information about each parameter may be obtained and illustrates certain dynamic properties of the structural model, normalized sensitivity indices provide a means for ascertaining the relative sensitivity across parameters and may add insight into the overall behavior of the system. 7 The computed values of the sensitivity coeffi cients for each parameter are provided in Table 2 . Model 2 is relatively insensitive at earlier times for perturbations in K D and R 0 , although maximum information for these parameters is obtained at earlier times ( Figures 5B  and 6B ). The model is highly sensitive at later times, with K D exhibiting a greater infl uence compared with R 0 . For Model 3, the output is sensitive at 5 hours for K D , and at later times, the model sensitivity is high for both K D and R 0 . Additionally, k int infl uenced model output the most at later times and k deg was least infl uential at 25 hours. For nonlinear models, a local sensitivity analysis does not provide conclusive results. Further studies should be conducted using a global sensitivity approach, wherein multiple parameters are changed simultaneously. 14 Such an approach will allow an assessment of parameter interactions, if any, within each model.
CONCLUSION
Selected TMDD models subjected to parameter perturbations were evaluated to gain a better understanding of model behavior. Local sensitivity analysis allowed the elucidation of model outcomes with respect to each parameter. All models were sensitive to perturbations in standard parameters of linear disposition. The infl uence of K D in the terminal phase for Model 3 necessitates sample measurements at later time points, and the relevance of early time points for accurate estimation of R 0 has been demonstrated. Thus, as highlighted in this study, informed study designs of TMDD systems may be of critical importance for the accurate estimation of infl uential model parameters. 
